These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6639232)

  • 41. [Fatal course of agranulocytosis during antiarryhthmic aprindine therapy].
    Hausamen TU; Weber FW
    Dtsch Med Wochenschr; 1977 Oct; 102(42):1523-4. PubMed ID: 913289
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aprindine-induced hepatic granulomata.
    Elisaf M; Stefanaki-Nikou S; Voulgarelis M; Masalas C; Tsianos EV
    J Hepatol; 1992 Mar; 14(2-3):276-9. PubMed ID: 1500691
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aprindine.
    Kesteloot H
    Circulation; 1976 Oct; 54(4):698. PubMed ID: 963856
    [No Abstract]   [Full Text] [Related]  

  • 45. Pharmacokinetic study of aprindine and moxaprindine in dogs.
    de Suray JM; Lavis A; Breekpot F
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):209-15. PubMed ID: 7251236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of moxaprindine treatment on ventricular arrhythmias occurring during maximal exercise stress testing.
    Kesteloot H; van de Werf F; Marchandise B; Sluyts R
    Acta Cardiol; 1979; 34(5):301-9. PubMed ID: 317204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of aprindine in patients with normal and pre-damaged impulse forming and excitation conducting system. Second communication: Conduction times (author's transl)].
    Pantlen H; Runge M; Luckmann E
    Arzneimittelforschung; 1980; 30(2):324-8. PubMed ID: 7378113
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of aprindine in ambulatory treatment].
    Hagemeijer F
    Coeur Med Interne; 1976; 15(3):447-51. PubMed ID: 991575
    [No Abstract]   [Full Text] [Related]  

  • 49. Agranulocytosis and aprindine.
    van Leeuwen R; Meyboom RH
    Lancet; 1976 Nov; 2(7995):1137. PubMed ID: 62971
    [No Abstract]   [Full Text] [Related]  

  • 50. Aprindine psychosis.
    Jacobs GP; Pores IH
    Am Heart J; 1980 Sep; 100(3):347-8. PubMed ID: 7405806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical study of a new antiarrhythmic agent: verapamil hydrochloride].
    Warembourg H; Bertrand ME; Ginestet A
    Lille Med; 1974 Oct; 19(8 Suppl 3):890-3. PubMed ID: 4463285
    [No Abstract]   [Full Text] [Related]  

  • 52. [Agranulocytosis after treatment with apridine].
    Baedeker W; Rastetter J
    MMW Munch Med Wochenschr; 1977 Aug; 119(32-33):1047-8. PubMed ID: 408649
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of aprindine in patients with normal and pre-damaged impulse forming and excitation conducting system/First communication; Sinus node function (author's transl)].
    Pantlen H; Runge M; Luckmann E
    Arzneimittelforschung; 1980; 30(1):92-5. PubMed ID: 7370079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aprindine: a review.
    Stoel I; Hagemeijer F
    Eur Heart J; 1980 Apr; 1(2):147-56. PubMed ID: 7026249
    [No Abstract]   [Full Text] [Related]  

  • 55. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up.
    Dagres N; Clague JR; Kottkamp H; Hindricks G; Breithardt G; Borggrefe M
    Eur Heart J; 1999 Dec; 20(24):1826-32. PubMed ID: 10581141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
    G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.
    Van Durme JP; Bogaert MG; Rosseel MT
    Eur J Clin Pharmacol; 1974 Aug; 7(5):343-6. PubMed ID: 4607575
    [No Abstract]   [Full Text] [Related]  

  • 59. [Long-term follow-up in patients receiving anticoagulation therapy: potency of therapy and complications].
    Katsuki T; Saito M; Noda T; Yaginuma T; Hosoda S
    J Cardiol; 1994; 24(3):203-9. PubMed ID: 8207635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Short and medium-term outcome after radiofrequency ablation of the atrioventricular junction].
    Mansourati J; Deharo JC; Graux P; Chappuis L; Durieu C; Dutoit A; Guillo P; Djiane P; Blanc JJ
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):945-51. PubMed ID: 9339255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.